Skip to content

Observational study; Prospective validation study Dutch version walking impairment Questionnaire (WIQ).

Observational study; Prospective validation study Dutch version Walking Impairment Questionnaire (WIQ).

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24806
Enrollment
30
Registered
2007-10-18
Start date
2007-10-22
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Peripheral arterial disease

Interventions

Supervised exercise therapy.

Sponsors

Dr. J.A.W Teijink Atrium medisch centrum Postbus 4446 6401 CX Heerlen J.Teijink@atriummc.nl
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Peripheral arterial disease, stage 2 according to Fontaine; 2. patients starting with supervised exercise therapy; 3. a maximal walking distance of < 750 meter, measured on a treadmill (using a progressive protocol of 3.2 km/h starting with 0% incline, increasing 2% every 2 minutes); 4. informed consent.

Exclusion criteria

Exclusion criteria: 1. Peripheral arterial disease (stage 3 or 4 acoording to Fontaine); 2. severe cardiopulmonary comorbidities (NYHA 3 or 4); 3. insufficient knowledge of the Dutch language; 4. unable to walk on a treadmill; 5. unable to walk without walking appliances; 6. familiar with supervised exercise therapy.

Design outcomes

Primary

MeasureTime frame
1. Internal consistency; 2. Test-retest reliability ; 3. Construct validity; 4. Concurrent validity.

Secondary

MeasureTime frame
Difference in walking ability on a treadmill compared with the walking ability outside at baseline and after three month of supervised exercise therapy.

Contacts

Public ContactJ.A.W Teijink

Postbus 4446

J.Teijink@atriummc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)